A series
of 73 ligands and 73 of their Cu+2 and Cu+1 copper
complexes with different geometries, oxidation states
of the metal, and redox activities were synthesized and characterized.
The aim of the study was to establish the structure–activity
relationship within a series of analogues with different substituents
at the N(3) position, which govern the redox potentials of the Cu+2/Cu+1 redox couples, ROS generation ability, and
intracellular accumulation. Possible cytotoxicity mechanisms, such
as DNA damage, DNA intercalation, telomerase inhibition, and apoptosis
induction, have been investigated. ROS formation in MCF-7 cells and
three-dimensional (3D) spheroids was proven using the Pt-nanoelectrode.
Drug accumulation and ROS formation at 40–60 μm spheroid
depths were found to be the key factors for the drug efficacy in the
3D tumor model, governed by the Cu+2/Cu+1 redox
potential. A nontoxic in vivo single-dose evaluation
for two binuclear mixed-valence Cu+1/Cu+2 redox-active
coordination compounds, 72k and 61k, was
conducted.